Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
about
Tests to assist in the diagnosis of cutaneous melanoma in adults: a generic protocolScreening for lung cancerScreening for lung cancerOlfactory detection of human bladder cancer by dogs: proof of principle studyCollagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancerA nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditionsProteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screeningExhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up studyDependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutantsDetection of cancer through exhaled breath: a systematic review.Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of CancerThe clinical potential of exhaled breath analysis for diabetes mellitusEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesA highly accurate inclusive cancer screening test using Caenorhabditis elegans scent detectionAssessment, origin, and implementation of breath volatile cancer markers.Significance of Exhaled Breath Test in Clinical Diagnosis: A Special Focus on the Detection of Diabetes Mellitus.The scent of disease: volatile organic compounds of the human body related to disease and disorderDiagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancersA pilot study exploring the use of breath analysis to differentiate healthy cattle from cattle experimentally infected with Mycobacterium bovisDiagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled MoleculesAdvances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath.Photoacoustic Spectroscopy for the Determination of Lung Cancer Biomarkers-A Preliminary Investigation.Detection of Volatile Organic Compounds by Self-assembled Monolayer Coated Sensor Array with Concentration-independent Fingerprints.Core-shell nanostructured hybrid composites for volatile organic compound detection.Detection biomarkers of lung cancer using mini-GC-PID system integrated with micro GC column and micro pre-concentratorBreath analysis in disease diagnosis: methodological considerations and applications.Conducting polymer-based nanohybrid transducers: a potential route to high sensitivity and selectivity sensorsBreath tests in respiratory and critical care medicine: from research to practice in current perspectivesIntegration of biosensors and drug delivery technologies for early detection and chronic management of illnessClinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.Advances in electronic-nose technologies developed for biomedical applications.Applications and advances in electronic-nose technologies.Real-time analysis of exhaled breath via resonance-enhanced multiphoton ionization-mass spectrometry with a medium pressure laser ionization source: observed nitric oxide profile.Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study.Noninvasive detection of lung cancer by analysis of exhaled breath.Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects.Use of fecal volatile organic compound analysis to discriminate between non-vaccinated and BCG-Vaccinated cattle prior to and after Mycobacterium bovis challenge.Short-Term Intra-Subject Variation in Exhaled Volatile Organic Compounds (VOCs) in COPD Patients and Healthy Controls and Its Effect on Disease ClassificationAnalysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: a feasibility study.
P2860
Q24186719-D3070259-62ED-4755-8194-4D35A46613CAQ24201867-32DE3706-99B8-4AEF-A96D-51E390239808Q24247464-D32796CD-934C-49BC-8793-5191295D0D38Q24564575-9E8B27CC-7F9B-4B43-A323-BB82FD241A2BQ24600990-DD886D02-AA21-4E31-92BA-163D73AE5229Q24610591-845F248C-1D99-4E0B-A135-3D2C935E0B07Q24685774-1C411A7D-5B58-40FC-B457-BCDABA7DAB42Q24813038-8C073B22-DB1A-472F-A17A-BC2685E413C6Q24817107-44D4E856-7477-4B63-8785-D51FF974DA71Q26781763-E9EE1436-123D-4130-AF4E-39C80B5D7A58Q26796389-93AECEB4-CFF3-426C-8354-3525D4E110A2Q27002406-EE173993-ECB2-4B8D-BB17-78B6406CCF1DQ27023830-FC9AD70E-944D-40C1-BF2F-C476AB31B951Q27313319-CC8173D3-9C8F-4673-9D87-2C78BAAAA1CCQ27692565-98AE3273-DFA0-4556-99C6-EF87EB5BDD24Q28078601-200E3444-EA89-45A2-BCED-A9405146BF19Q28243639-55F8DFBF-E845-4700-BD26-996016D00130Q28297937-3663FA80-6554-4602-9729-3985CAB04E9CQ28540085-8C7658ED-88F0-49F6-AFA4-F628BF1D131FQ28818128-6E127B4D-B069-4A92-A322-CABA306EFFC2Q29109861-CE9F8242-CACE-417D-9228-D90BC5BFBCBBQ30363643-953CDD7B-9779-4336-AA12-9FFAE88D155EQ30386441-7D3F0516-F61A-4300-AAB3-0A601010D163Q30403274-C4D18C6F-6A19-4473-A657-98AE4768777BQ30428001-5D0F6D32-DD57-434E-9716-FEBFC429791FQ30434697-CBF355BE-F626-4716-8354-47D7BFAB6B0FQ30441541-F334F86A-B641-4D26-9050-BC5D893CBE41Q30448113-EB33EBD0-1813-41F7-B1AB-1AC420B48A4AQ30451853-7E98A305-9BC5-4E60-A729-92D563EFC95BQ30458972-F15A5474-412F-436C-9BFE-15CA733AC469Q30470504-AB58588C-CD91-42FF-8A13-A1307D6FA6BEQ30470539-FA53B459-1F2A-4EC2-A038-80F77F18F256Q33236789-7ED39B57-CA3C-401C-BA2D-C0446F4D0F9CQ33435548-47F3B9EB-9A55-45E1-93D5-E61D72C1040DQ33475926-FA0B4EE8-3BDE-4D5A-9535-E3CBD2863930Q33507435-19BF8874-BEA4-491F-97F8-F78F926D9D3DQ33713144-86BCA695-CC16-42B1-A09C-3276F924A9B7Q33883795-E2E1B7B4-4434-4E14-B42F-5C7810328411Q33912670-EE384F01-6EB9-41F5-9A49-1850CFCC9468Q34051977-457DC12D-3316-445B-A8F7-38226E40AB7A
P2860
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
@ast
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
@en
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
@nl
type
label
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
@ast
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
@en
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
@nl
prefLabel
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
@ast
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
@en
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
@nl
P2093
P1433
P1476
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
@en
P2093
J Greenberg
J M Hughes
M Phillips
R N Cataneo
P304
P356
10.1016/S0140-6736(98)07552-7
P407
P577
1999-06-01T00:00:00Z